Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1 | 65049850 | intron variant | A/G | snv | 5.8E-02 |
|
0.800 | 1.000 | 1 | 2013 | 2013 | ||||||||||
|
1 | 65049850 | intron variant | A/G | snv | 5.8E-02 |
|
0.800 | 1.000 | 1 | 2013 | 2013 | ||||||||||
|
0.763 | 0.120 | 1 | 64846664 | missense variant | C/A | snv |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 4 | 2009 | 2011 | ||||||||
|
0.763 | 0.120 | 1 | 64846664 | missense variant | C/A | snv |
|
Neoplasms | 0.700 | 1.000 | 2 | 2011 | 2011 | ||||||||
|
1.000 | 0.040 | 1 | 64848529 | intron variant | C/A | snv | 7.3E-03 |
|
0.700 | 1.000 | 2 | 2016 | 2019 | ||||||||
|
0.763 | 0.120 | 1 | 64846664 | missense variant | C/A | snv |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2005 | 2005 | ||||||||
|
0.763 | 0.120 | 1 | 64846664 | missense variant | C/A | snv |
|
Neoplasms | 0.700 | 1.000 | 1 | 2009 | 2009 | ||||||||
|
1.000 | 0.040 | 1 | 64877383 | intron variant | A/G | snv | 0.16 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1 | 64947147 | intron variant | G/A;T | snv |
|
0.700 | 1.000 | 1 | 2019 | 2019 | |||||||||||
|
1.000 | 0.040 | 1 | 64848529 | intron variant | C/A | snv | 7.3E-03 |
|
Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
1.000 | 0.040 | 1 | 64848529 | intron variant | C/A | snv | 7.3E-03 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
1 | 64957764 | intron variant | G/A | snv | 6.1E-02 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||||
|
1 | 64957764 | intron variant | G/A | snv | 6.1E-02 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||||
|
1.000 | 0.120 | 1 | 64846699 | missense variant | G/A | snv |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
1.000 | 0.120 | 1 | 64863417 | intron variant | C/T | snv | 0.35 |
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases; Endocrine System Diseases | 0.700 | 1.000 | 1 | 2015 | 2015 | |||||||
|
1.000 | 0.040 | 1 | 64884439 | intron variant | A/G | snv | 0.43 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 1 | 64883925 | intron variant | A/G | snv | 0.37 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 1 | 64883861 | intron variant | A/G;T | snv |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
1.000 | 0.040 | 1 | 64875884 | 3 prime UTR variant | C/T | snv | 0.15 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.200 | 1 | 64873549 | 3 prime UTR variant | A/G | snv | 1.0E-02 | 3.6E-03 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
1.000 | 0.200 | 1 | 64873549 | 3 prime UTR variant | A/G | snv | 1.0E-02 | 3.6E-03 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
1 | 64905735 | intron variant | C/T | snv | 5.6E-02 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
1 | 65006640 | intron variant | A/G | snv | 0.22 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
1.000 | 0.040 | 1 | 64969742 | intron variant | C/G | snv | 0.18 |
|
Endocrine System Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.882 | 1 | 64895266 | intron variant | A/T | snv | 0.15 |
|
Immune System Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 |